ซักซ้อมความเข้าใจเกี่ยวกับการให้บริการแก่ลูกค้าในการซื้อขายและการส่งมอบ/รับมอบสินค้า (physical delivery) ของสัญญาซื้อขายล่วงหน้าที่มีสินค้าเกษตรเป็นสินค้าอ้างอิง ("สินค้าเกษตรล่วงหน้า")

sale category of brand ZIGA amounting to THB 172.7 mn and brand DAIWA amounting to THB 23.7 mn. The mainly factor of the decrease in sales revenue of the product category ZIGA which was a decline in

, respectively. • The decrease was mainly from the decline in operating revenue due to the temporary closure of dine-in areas from late of March to mid-May. Gross Profit and Gross Profit Margin • The Company’s

international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug

Company had services income from digital content of THB 52.79 million, decreased by THB 13.49 million or -20.35% YoY. This was due to the decline in average user spending on digital content services. The

ordered a large volume of products. Delivery of the products has gradually been made since Q1/2018. The Company had shareholders’ equity of Baht 285.73 million as at March 31, 2018, a slight decline by Baht

, decreased by THB 28.38 million or -37.51% YoY. This was due to the decline in average user spending on digital content services, mainly due to a decrease in marketing promotional activities by mobile

2018, Sales revenue of the Company was recorded at THB 1,256.44 million and THB 983.36 million respectively or equivalent to a drop of 21.73% which is considered a consecutive decline from the last

. Sales in 1Q18 represented new prices for delivery that took effect in January 2018 with an effective markdown of nearly 2%. Cost of Sales and Gross Profit The profit margin in 1Q18 dropped Q-o-Q and Y-o-Y

2019 was equal to 135.0 million baht lower than the third quarter of 2018 at 12.8 percent. For total revenues for the third quarter in 2019 was 158.0 million Baht a decline by 7.5percent from the same